Kernalbio creates mRNA therapies that instruct specific cells on how to make their own medicine.
Kernal Biologics's investors include Y Combinator, Gaingels, Hummingbird Ventures, HOF Capital, The Boeing Company.
Kernal Biologics is headquartered in Cambridge, United States.
Kernalbio creates mRNA therapies that instruct specific cells on how to make their own medicine.
Kernal Biologics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Kernal Biologics — Funding & Investors." VCBacked, October 7, 2025, https://www.vcbacked.co/company/kernal-biologics. Accessed September 30, 2026.
VCBacked. (2025). Kernal Biologics — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/kernal-biologics
{{cite web |title=Kernal Biologics — Funding & Investors |url=https://www.vcbacked.co/company/kernal-biologics |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated